Brazil has made significant progress in its HIV response, but the country is also experiencing a rise in new infections, according to a report from UNAIDS. The findings were reported by Folha de S.Paulo on Tuesday.
The UNAIDS report highlights a mixed picture for Brazil. While treatment and prevention efforts have improved in some areas, the overall number of HIV cases is growing, signaling a potential setback in the fight against the epidemic. Folha de S.Paulo notes that this trend is part of a broader global concern, with the UN warning that the HIV epidemic could resurge worldwide.
The report comes amid growing alarm over declining investment in HIV programs. According to G1 and Estadão, a historic drop in funding is threatening the global response to AIDS. This financial shortfall is putting past gains at risk and making it harder to sustain prevention and treatment campaigns.
At the AIDS 2026 conference, activists protested at the Gilead Sciences booth, demanding broader access to the drug lenacapavir. As reported by Mídia NINJA, protesters chanted “Tested in Brazil, denied to Brazilians,” criticizing the company for making the drug unavailable in the country where it was tested. The demonstration underscores tensions between pharmaceutical development and equitable access.
The UNAIDS report and the protests in Amsterdam point to a critical juncture. The next steps for Brazil and the global community will depend on reversing funding cuts and ensuring new treatments reach those who need them.
